Published in Blood Cancer J on April 01, 2011
Current concepts in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia. Front Oncol (2014) 0.97
Chimeric Mouse model to track the migration of bone marrow derived cells in glioblastoma following anti-angiogenic treatments. Cancer Biol Ther (2016) 0.90
Imaging CXCL12-CXCR4 signaling in ovarian cancer therapy. PLoS One (2013) 0.88
Treatment of acute lymphoblastic leukemia with an rGel/BLyS fusion toxin. Leukemia (2012) 0.83
5T4 oncofetal antigen is expressed in high risk of relapse childhood pre-B acute lymphoblastic leukemia and is associated with a more invasive and chemotactic phenotype. Leukemia (2012) 0.81
A CXCR4-targeted site-specific antibody-drug conjugate. Angew Chem Int Ed Engl (2014) 0.79
Delivery of siRNA Using CXCR4-targeted Nanoparticles Modulates Tumor Microenvironment and Achieves a Potent Antitumor Response in Liver Cancer. Mol Ther (2015) 0.77
CXCR4 antagonists suppress small cell lung cancer progression. Oncotarget (2016) 0.75
Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med (2005) 7.01
Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100. Blood (2008) 3.77
Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML. Blood (2008) 3.67
CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy. Blood (2009) 3.37
Effects of inhibitors of the chemokine receptor CXCR4 on acute lymphoblastic leukemia cells in vitro. Leukemia (2003) 1.40
CXCR4 antagonists mobilize childhood acute lymphoblastic leukemia cells into the peripheral blood and inhibit engraftment. Leukemia (2007) 1.32
Resistance to imatinib of bcr/abl p190 lymphoblastic leukemia cells. Cancer Res (2006) 1.28
Nilotinib treatment in mouse models of P190 Bcr/Abl lymphoblastic leukemia. Mol Cancer (2007) 1.11
Identification of an altered immunoglobulin heavy-chain gene rearrangement in the central nervous system in B-precursor acute lymphoblastic leukemia. Leukemia (1993) 0.83
Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell (1984) 6.78
A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia. Nature (1982) 5.95
Structure and biological activity of v-raf, a unique oncogene transduced by a retrovirus. Proc Natl Acad Sci U S A (1983) 4.82
Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction. Nat Genet (1995) 4.77
Localization of the c-ab1 oncogene adjacent to a translocation break point in chronic myelocytic leukaemia. Nature (1984) 4.30
Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res (1995) 4.28
Structural organization of the bcr gene and its role in the Ph' translocation. Nature (1985) 4.08
The AGAMOUS-LIKE 20 MADS domain protein integrates floral inductive pathways in Arabidopsis. Genes Dev (2000) 3.90
High-level semi-synthetic production of the potent antimalarial artemisinin. Nature (2013) 3.80
Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts. Cancer Res (1998) 3.39
Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science (1996) 3.35
B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes. J Immunol (1983) 3.09
The relative importance of social versus commercial sources in youth access to tobacco, alcohol, and other drugs. Prev Med (2000) 3.07
Role of ER export signals in controlling surface potassium channel numbers. Science (2001) 2.93
Acute leukaemia in bcr/abl transgenic mice. Nature (1990) 2.93
Immobilization of Notch ligand, Delta-1, is required for induction of notch signaling. J Cell Sci (2000) 2.57
Comparison of the autoSCAN-W/A rapid bacterial identification system and the Vitek AutoMicrobic system for identification of gram-negative bacilli. J Clin Microbiol (1991) 2.51
Molecular biology of Hendra and Nipah viruses. Microbes Infect (2001) 2.33
Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia. Cell (1987) 2.27
The exceptionally large genome of Hendra virus: support for creation of a new genus within the family Paramyxoviridae. J Virol (2000) 2.26
Evaluation of the novel myocardial perfusion positron-emission tomography tracer 18F-BMS-747158-02: comparison to 13N-ammonia and validation with microspheres in a pig model. Circulation (2009) 2.15
Free energy balance in protein folding. Adv Protein Chem (1995) 2.10
The Notch ligand, Jagged-1, influences the development of primitive hematopoietic precursor cells. Blood (1998) 2.05
Effect of long-term mild hypothermia therapy in patients with severe traumatic brain injury: 1-year follow-up review of 87 cases. J Neurosurg (2000) 2.04
Chronic conditions, physical limitations and dependency among seniors living in the community. Health Rep (1996) 1.98
Endogenous, hyperactive Rac3 controls proliferation of breast cancer cells by a p21-activated kinase-dependent pathway. Proc Natl Acad Sci U S A (2000) 1.97
Chromosomal localization of human cellular homologues of two viral oncogenes. Nature (1982) 1.96
Tissue-specific expression and dietary regulation of a chimeric phosphoenolpyruvate carboxykinase/bovine growth hormone gene in transgenic mice. J Biol Chem (1988) 1.91
Sphingosine 1-phosphate induces angiogenesis: its angiogenic action and signaling mechanism in human umbilical vein endothelial cells. Biochem Biophys Res Commun (1999) 1.90
Gamma delta beta-thalassaemias 1 and 2 are the result of a 100 kbp deletion in the human beta-globin cluster. Nucleic Acids Res (1986) 1.90
Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation. Biochem Biophys Res Commun (1997) 1.87
Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res (1994) 1.86
Funisitis and chorionic vasculitis: the histological counterpart of the fetal inflammatory response syndrome. J Matern Fetal Neonatal Med (2002) 1.83
REP1, a basic helix-loop-helix protein, is required for a branch pathway of phytochrome A signaling in arabidopsis. Plant Cell (2000) 1.83
p53 mutation is infrequent in clear cell carcinoma of the ovary. Gynecol Oncol (2001) 1.83
Assessment of the total number of human transcription units. Genomics (2001) 1.82
Characterization of RAC3, a novel member of the Rho family. J Biol Chem (1997) 1.82
Gefitinib in patients with chemo-sensitive and chemo-refractory relapsed small cell cancers: a Hoosier Oncology Group phase II trial. Lung Cancer (2006) 1.77
Isolation and chromosomal localization of CRKL, a human crk-like gene. Oncogene (1993) 1.76
Prospective study of fibrinolytic factors and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb Vasc Biol (2001) 1.73
The chronic myelocytic cell line K562 contains a breakpoint in bcr and produces a chimeric bcr/c-abl transcript. Mol Cell Biol (1986) 1.72
Mitochondrial dynamics regulates migration and invasion of breast cancer cells. Oncogene (2012) 1.69
A novel type of secondary modification of two CCGG residues in the human gamma delta beta-globin gene locus. Nucleic Acids Res (1980) 1.67
Stabilization of ion selectivity filter by pore loop ion pairs in an inwardly rectifying potassium channel. Proc Natl Acad Sci U S A (1997) 1.67
Molecular recognition of acute myeloid leukemia using aptamers. Leukemia (2009) 1.63
Tioman virus, a novel paramyxovirus isolated from fruit bats in Malaysia. Virology (2001) 1.62
Evidence of a new chimeric bcr/c-abl mRNA in patients with chronic myelocytic leukemia and the Philadelphia chromosome. N Engl J Med (1985) 1.61
A genomewide suppressor and enhancer analysis of cdc13-1 reveals varied cellular processes influencing telomere capping in Saccharomyces cerevisiae. Genetics (2008) 1.58
Nitric oxide as a bioregulator of apoptosis. Biochem Biophys Res Commun (2001) 1.57
MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment. Leukemia (2007) 1.57
Radiosurgery for brain metastases from primary lung carcinoma. Cancer J (2001) 1.57
The Saccharomyces cerevisiae DNA repair gene RAD25 is required for transcription by RNA polymerase II. Genes Dev (1993) 1.57
Influence of in vitro susceptibility testing conditions on the anti-candidal activity of LY121019. Diagn Microbiol Infect Dis (1988) 1.57
Nitric oxide activates skeletal and cardiac ryanodine receptors. Cell Calcium (1997) 1.56
A novel abl protein expressed in Philadelphia chromosome positive acute lymphoblastic leukaemia. Nature (1987) 1.56
Evaluation of a continuous cardiac output and mixed venous oxygen saturation catheter in critically ill surgical patients. Crit Care Med (1997) 1.52
The role of infection in preterm labour and delivery. Paediatr Perinat Epidemiol (2001) 1.52
B cell origin of non-T cell acute lymphoblastic leukemia. A model for discrete stages of neoplastic and normal pre-B cell differentiation. J Clin Invest (1984) 1.51
Fasting augments lipid peroxidation during reperfusion after ischemia in the perfused rat liver. Crit Care Med (1999) 1.50
Strong constraints on the rare decays B(s)(0) → μ+ μ- and B0 → μ+ μ-. Phys Rev Lett (2012) 1.50
First observation of the decays B(0) → D(+)K(-)π(+)π(-) and B(-) → D(0)K(-)π(+)π(-). Phys Rev Lett (2012) 1.50
Radiosurgery for brain metastases: is whole brain radiotherapy necessary? Int J Radiat Oncol Biol Phys (1999) 1.50
Calibration of HCV working reagents for NAT assays against the HCV international standard. The Collaborative Study Group. Vox Sang (2000) 1.49
Purification and some properties of carbon monoxide dehydrogenase from Pseudomonas carboxydohydrogena. J Bacteriol (1981) 1.48
Evidence that the nucleotide exchange and hydrolysis cycle of G proteins causes acute desensitization of G-protein gated inward rectifier K+ channels. Proc Natl Acad Sci U S A (1998) 1.46
Neonates born to pre-eclamptic mothers have a higher percentage of natural killer cells (CD3-/CD56+16+) in umbilical cord blood than those without pre-eclampsia. J Matern Fetal Neonatal Med (2003) 1.44
Growth and mineral metabolism in very low birth weight infants. II. Effects of calcium supplementation on growth and divalent cations. Pediatr Res (1975) 1.44
Targeting nitric oxide (NO) delivery in vivo. Design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-alpha-induced apoptosis and toxicity in the liver. J Med Chem (1997) 1.44
Involvement of the tyrosine kinase fer in cell adhesion. Mol Cell Biol (1998) 1.44
HuD RNA recognition motifs play distinct roles in the formation of a stable complex with AU-rich RNA. Mol Cell Biol (2000) 1.44
Gamma knife radiosurgery in children. Pediatr Neurosurg (1996) 1.43
Isolation and sequence analysis of a novel human tyrosine kinase gene. Mol Cell Biol (1989) 1.43
Transforming growth factor-beta3 regulates transdifferentiation of medial edge epithelium during palatal fusion and associated degradation of the basement membrane. Dev Dyn (1997) 1.42
ABR, an active BCR-related gene. Nucleic Acids Res (1989) 1.42
TGF-beta3-induced palatogenesis requires matrix metalloproteinases. Mol Biol Cell (2001) 1.42
Molecular recognition of tRNA by tRNA pseudouridine 55 synthase. Biochemistry (1998) 1.42
Prospective assessment of estrogen replacement therapy and cognitive functioning: atherosclerosis risk in communities study. Am J Epidemiol (2001) 1.41
Five-color-based high-information-content fingerprinting of bacterial artificial chromosome clones using type IIS restriction endonucleases. Genomics (2001) 1.40
Hypoceruloplasminemia-related movement disorder without Kayser-Fleischer rings is different from Wilson disease and not involved in ATP7B mutation. Eur J Neurol (2009) 1.40
The human tyrosine kinase gene (FER) maps to chromosome 5 and is deleted in myeloid leukemias with a del(5q). Cytogenet Cell Genet (1990) 1.39
A genetic linkage map of mouse chromosome 10: localization of eighteen molecular markers using a single interspecific backcross. Genetics (1990) 1.39